Document Detail


Remedies for HIV-associated peripheral neuropathy.
MedLine Citation:
PMID:  10851359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
J R Berger; A Nath
Related Documents :
22537369 - Chronic hepatitis in man and in dog: a comparative update.
20880749 - Hiv-associated tuberculous meningitis--diagnostic and therapeutic challenges.
23669229 - Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in hiv c...
21740849 - Heterosexual risk of hiv infection in china: systematic review and meta-analysis.
2220309 - Ventricle brain ratio in the clinical course of hiv infection.
3323389 - Synthesis of hepatic lipase in liver and extrahepatic tissues.
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Neurology     Volume:  54     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-07-13     Completed Date:  2000-07-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2037-8     Citation Subset:  AIM; IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-HIV Agents / therapeutic use*
HIV Infections / complications,  drug therapy*
Humans
Nerve Growth Factor / therapeutic use*
Peripheral Nervous System Diseases / drug therapy*,  virology
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 9061-61-4/Nerve Growth Factor
Comments/Corrections
Comment On:
Neurology. 2000 Jun 13;54(11):2115-9   [PMID:  10851374 ]
Neurology. 2000 Mar 14;54(5):1080-8   [PMID:  10720278 ]
Neurology. 2000 Jun 13;54(11):2120-7   [PMID:  10851375 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A case of congenital pseudarthrosis of the tibia treated with pulsing electromagnetic fields. 17-yea...
Next Document:  A comparative study of the relative bioavailability of different interferon beta preparations.